Lexaria Bioscience Corp. — Form D

Lexaria Bioscience Corp. of KELOWNA, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-02. The offering totals $365K, of which $365K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Christopher BunkaExecutive OfficerKelowna, A1
Nelson CabatuanExecutive OfficerKelowna, A1
Bal Edward BhullarDirectorKelowna, A1
John DochertyDirectorKelowna, A1
John DochertyExecutive OfficerKelowna, A1
Michael ShankmanExecutive OfficerKelowna, A1
William Edward McKechnieDirectorKelowna, A1
ALBERT Edward REESEDirectorKelowna, A1
Nicholas BaxterDirectorKelowna, A1
Richard ChristopherDirectorKelowna, A1
Richard ChristopherExecutive OfficerKelowna, A1
Christopher BunkaDirectorKelowna, A1
Allan SpissingerExecutive OfficerKelowna, A1
Brian QuigleyDirectorRichmond, VA
CATHERINE TURKELDirectorKelowna, A1
ALBERT REESEDirectorKelowna, A1
TED MCKECHNIEDirectorKelowna, A1
Nicholas W BaxterDirectorVancouver, A1
GREGORY DOWNEYExecutive OfficerKelowna, A1
CHRIS BUNKADirectorKelowna, A1
CHRIS BUNKAExecutive OfficerKelowna, A1
John Martin DochertyDirectorKelowna, A1
John Martin DochertyExecutive OfficerKelowna, A1
Ted W McKechnieDirectorKitchener, A6
Allan W SpissingerExecutive OfficerKelowna, A1

Other filings by this issuer (13)

FiledFormOfferingSold
2025-12-19D$3.5M$3.5M
2025-10-01D$4.0M$4.0M
2024-10-16D$5.0M$5.0M
2024-02-16D$3.6M$3.6M
2023-10-04D$1.6M$1.6M
2021-12-20D$1.2M$1.2M
2021-07-27D$85K$85K
2020-07-08D$100K$100K
2020-05-13D$2.0M$2.0M
2019-11-19D$2.4M$493K
2019-11-13D$180K$180K
2018-11-15D$310K$310K
2016-09-13D$109K$109K

More